LENTIVIRAL-MEDIATED GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA [GROUP A]: UPDATED RESULTS FROM GLOBAL RP-L102 CLINICAL TRIALS

被引:0
|
作者
Sevilla, Julian [1 ,2 ]
Booth, Claire [3 ]
Czechowicz, Agnieszka [4 ,5 ]
Agarwal, Rajni [4 ,5 ]
Zubicaray, Josune [1 ]
Rio, Paula [2 ,6 ,7 ]
Chetty, Kritika [3 ]
O'Toole, Grainne [3 ]
Xu-Bayford, Jinhua [3 ]
Ancliff, Philip [3 ]
Sebastian, Elena [1 ]
Choi, Grace [8 ]
Zeini, Miriam [8 ]
Nicoletti, Eileen [8 ]
Eide, Cindy [9 ]
Wagner, John [9 ]
Rao, Gayatri [8 ]
Thrasher, Adrian [3 ]
Schwartz, Jonathan [8 ]
Roncarolo, Maria Grazia [4 ,5 ]
Bueren, Juan [2 ,6 ,7 ]
机构
[1] Hosp Infantil Univ Nino Jesus HIUNJ, Fdn Invest Biomed, Madrid, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain
[3] UCL Great Ormond St Inst Child Hlth, London, England
[4] Stanford Univ, Sch Med, Stanford, CA USA
[5] Lucile Packard Childrens Hosp, Palo Alto, CA USA
[6] Ctr Invest Energet Medioambientales & Tecnolog CI, Madrid, Spain
[7] Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Madrid, Spain
[8] Rocket Pharmaceut Inc, Cranbury, NJ USA
[9] Univ Minnesota, Minneapolis, MN USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P182
引用
收藏
页码:276 / 277
页数:2
相关论文
共 50 条
  • [21] RP-L301, a Lentiviral-Mediated Gene Therapy for Pyruvate Kinase Deficiency (PKD): A Phase 2 Clinical Trial Design
    Shah, Ami J.
    Lorenzo, Jose Luis Lopez
    Grace, Rachael F.
    Beers, E. J. van
    Bartels, M.
    Glenthoej, Andreas
    Navarro, Susana
    Llanos, Lucia
    Gaisse, Begona Perez de Camino
    Sanchez, Sol
    Zubicaray, Josune
    Chien, May
    Bustamante, Oscar Quintana
    Gonzalez-Vicent, M.
    Iriondo, June
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Chitty-Lopez, Maria
    Rao, Gayatri R.
    Bueren, Juan
    Schwartz, Jonathan
    Segovia, Jose Carlos
    Sevilla, Julian
    BLOOD, 2024, 144 : 35831 - 35832
  • [22] LENTIVIRAL-MEDIATED GENE THERAPY FOR SEVERE PYRUVATE KINASE DEFICIENCY: GLOBAL PHASE 1 STUDY RESULTS
    Shah, Ami
    Lorenzo, Jose Luis Lopez
    Sevilla, J.
    Navarro, Susana
    Llanos, Lucia
    Gaisse, Begona Perez De Camino
    Sanchez, Sol
    Zubicaray, Josune
    Glader, Bertil
    Chien, May
    Bustamante, OQuintana
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Rao, Gayatri
    Roncarolo, Maria Grazia
    Bueren, Juan
    Schwartz, J.
    Segovia, Jose Carlos
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S133 - S134
  • [23] LENTIVIRAL-MEDIATED GENE THERAPY FOR SEVERE PYRUVATE KINASE DEFICIENCY: RESULTS FROM AN ONGOING GLOBAL PHASE 1 STUDY
    Lopez Lorenzo, Jose Luis
    Shah, Ami
    Sevilla, Julian
    Navarro, Susana
    Llanos, Lucia
    de Camino Gaisse, Begona Perez
    Sanchez, Sol
    Zubicaray, Josune
    Glader, Bertil
    Chien, May
    Quintana Bustamante, Oscar
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Rao, Gayatri
    Roncarolo, Maria Grazia
    Bueren, Juan
    Schwartz, Jonathan
    Carlos Segovia, Jose
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 275 - 276
  • [24] Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs
    Javier Molina-Estevez, F.
    Nowrouzi, Ali
    Lozano, MLuz
    Galy, Anne
    Charrier, Sabine
    von Kalle, Christof
    Guenechea, Guillermo
    Bueren, Juan A.
    Schmidt, Manfred
    CURRENT GENE THERAPY, 2015, 15 (06) : 550 - 562
  • [25] Changing the Natural History of Fanconi Anemia Complementation Group-A with Gene Therapy: Early Results of US Phase I Study of Lentiviral-Mediated Ex-VivoFANCA Gene Insertion in Human Stem and Progenitor Cells
    Czechowicz, Agnieszka
    Roncarolo, Maria Grazia
    Beard, Brian C.
    Law, Ken
    Nicoletti, Eileen
    Rio, Paula
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Soni, Sandeep
    BLOOD, 2019, 134
  • [26] Lentiviral-mediated Gene Therapy for Adults and Children with Severe Pyruvate Kinase Deficiency: Results from an Ongoing Global Phase 1 Study
    Shah, Ami J.
    Lopez Lorenzo, Jose Luis
    Sevilla, Julian
    Navarro, Susana
    Llanos, Lucia
    de Camino Gaisse, Begona Perez
    Sanchez, Sol
    Zubicaray, Josune
    Glader, Bert
    Chien, May
    Bustamante, Oscar Quintana
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Rao, Gayatri R.
    Grazia Roncarolo, Maria
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Segovia, Jose C.
    BLOOD, 2022, 140 : 4902 - 4903
  • [27] Lentiviral-Mediated Preclinical Studies for the Gene Therapy of RPS19-Deficient Diamond-Blackfan Anemia Patients
    Gimenez, Yari
    Sanchez, Rebeca
    Zorbas, Christiane
    Palacios, Manuel
    Ugalde, Laura
    Alberquilla, Omaira
    Galvez, Eva
    Strullu, Marion
    Carlos Segovia, Jose
    Catala, Albert
    Rio, Paula
    Sevilla, Julian
    Belendez, Cristina
    Lafontaine, Denis
    Leblanc, Thierry
    Bueren, Juan
    Navarro, Susana
    MOLECULAR THERAPY, 2020, 28 (04) : 352 - 352
  • [28] Changing the Natural History of Fanconi Anemia Complementation Group-A with Gene Therapy: Early Results of US Phase I Study of Lentiviral-Mediated Ex-Vivo FANCA Gene Insertion in Human Stem and Progenitor Cells
    Czechowicz, Agnieszka
    Rio, Paula
    Bueren, Juan E.
    Beard, Brian
    Nicoletti, Eileen
    Schwartz, Jonathan
    Soni, Sandeep
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S39 - S40
  • [29] Towards the lentiviral gene therapy of mobilized CD34+Cells from Fanconi anemia patients
    Bueren, Juan A.
    HUMAN GENE THERAPY, 2014, 25 (11) : A12 - A12
  • [30] Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency: Updated Results of a Global Phase 1 Study for Adult and Pediatric Patients
    Lopez Lorenzo, Jose Luis
    Shah, Ami J.
    Navarro, Susana
    Sevilla, Julian
    Llanos, Lucia
    Perez Camino de Gaisse, Begona
    Sanchez, Sol
    Glader, Bertil
    Chien, May
    Quintana-Bustamante, Oscar
    Beard, Brian C.
    Law, Kenneth M.
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Rao, Gayatri R.
    Roncarolo, Maria Grazia
    Bueren, Juan A.
    Schwartz, Jonathan D.
    Segovia, Jose C.
    MOLECULAR THERAPY, 2021, 29 (04) : 42 - 43